Statistics
Publications
15
Citations
668
H-Index
14
Active since
2018
Lijie Xing is an author at Dana-Farber Cancer Institute specializing in multiple myeloma, multiple myeloma therapy, and cancer immunotherapy.
Publications per year
2018–2024
15
15
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
Liang Lin, Shih‐Feng Cho, Lijie Xing et al. · Leukemia · 2020 · 89 citations · Full text
Life Sciences, Immunology, Oncology +14
Lijie Xing, Liang Lin, Tengteng Yu et al. · Leukemia · 2020 · 62 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 15